Cyclazocine

Cyclazocine

Systematic (IUPAC) name
3-(Cyclopropylmethyl)-6,11-dimethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-8-ol or 2-Cyclopropylmethyl-2'-hydroxy-5,9-dimethyl-6,7-benzomorphan
Clinical data
Legal status	?
Routes of administration	Oral
Identifiers
CAS Number	7346-09-0 N
ATC code	none
PubChem	CID: 19143
IUPHAR/BPS	1604
ChemSpider	18063 Y
UNII	J5W1B1159C Y
KEGG	D03618 Y
ChEMBL	CHEMBL56585 N
Chemical data
Formula	C18H25NO
Molecular mass	271.40 g/mol
SMILES Oc1ccc4c(c1)C2(C(C(N(CC2)CC3CC3)C4)C)C
InChI InChI=1S/C18H25NO/c1-12-17-9-14-5-6-15(20)10-16(14)18(12,2)7-8-19(17)11-13-3-4-13/h5-6,10,12-13,17,20H,3-4,7-9,11H2,1-2H3 Y Key:YQYVFVRQLZMJKJ-UHFFFAOYSA-N Y
NY (what is this?)  (verify)

Cyclazocine is a mixed opioid agonist/antagonist related to dezocine, pentazocine and phenazocine. This family of opioid drugs is called the benzomorphans or benzazocines. It is a KOR agonist and MOR partial agonist, and also has high affinity for the DOR.

Use

Research into the use of cyclazocine for the treatment of bipolar patients with depression was undertaken by Fink and colleagues (1970). It showed that 8 out of 10 patients experienced moderate improvement.

Research during the 1960s and 1970s into the possible use of cyclazocine for management of pain, and later for assisting treatment of narcotic addiction was severely hampered by the drug's psychotomimetic, dysphoric, and hallucinatory effects.

See also

• Benzomorphan